Following the astronomical increase in the prices of drugs, some residents of the Federal Capital Territory (FCT) have resorted to herbal concoctions commonly referred to as agbo to treat various illnesses.
The prices of many prescribed and over-the-counter medications have steadily increased, making these drugs unaffordable and unavailable.
Findings revealed that some pharmacies in the Federal Capital Territory (FCT), where some drugs were reported to be scarce or unavailable, such as Augmentin, multivitamins like Omega H3, Ventolin inhaler and Fleming antibiotics.
A pharmacist, who spoke anonymously said, GlaxoSmithKline (GSK) products are now scarce and expensive since the company announced its exit from Nigeria. For the GSK products, we have the example of Paracetamol, which a single card was being sold at N200, but now has increased to N400.
In one of the big pharmacies visited, Ventolin inhaler sells at N8, 870 against N2, 000; while Augmentin sells for between N23, 000 to 25,000, as against N3, 000 to N5, 000 it was sold before the GSK exit.
Nicholas Adah, a cleaner, said he was advised by his friend to take agbo, after sharing his symptoms with him. On his part, a vulcaniser, Wasiu Ahmed, said: Why would I go and spend money that I do not even have to buy medicine from a chemist when I can take agbo?
Similarly, a taxi driver, Sunny Adeniyi, said he preferred to take agbo to treat his ailments because it is effective and cheaper than orthodox medicine. Also, an agbo seller, Sisi Ayo, who said she has been in the business for a while, said she got new customers regularly, both educated and uneducated people.
Theresa Okafor, a retiree and widow who is hypertensive, said the prices of all her medications had increased by 10 per cent to 40 per cent, and she could no longer afford to buy some of them. Ms. Okafor, who said the cost depended on brand name and availability, added that her physician had to replace some drugs with cheaper brands.
Pharmacist, Jelili Kilani attributed the increasing cost of medication to the high cost of foreign exchange and the cost of production for locally-made drugs. He said there must be a deliberate attempt by the government to ensure a reduction in the cost of production and the removal of duties on imported items.
The pharmacist advised those taking agbo to be careful, especially buying from hawkers.
In August, GlaxoSmithKline Consumer Nigeria Plc announced it was halting operations. Also, a French pharmaceutical multi-national maker of polio vaccines, Sanofi, also announced its exit from Nigerian operations in November. The company said it had appointed a third-party distributor to handle its commercial portfolio of medicines starting in February, 2024.
